Innovative Health Tech Kepley BioSystems has developed a rapid and affordable blood screening tool capable of early diagnosis of sepsis, indicating strong potential for partnerships with healthcare providers, hospitals, and diagnostic labs seeking cost-effective, cutting-edge medical solutions.

Research and Funding Growth With recent NSF funding of $1 million supporting its synthetic fish bait research and other innovations, the company demonstrates active engagement in grant programs, creating opportunities to offer supplementary research tools, collaboration proposals, and government-funded project funding support.

Collaborative Innovation Operating from a research park in partnership with universities, Kepley BioSystems is positioned to leverage academic collaborations, providing a pathway to access advanced research instrumentation, biotech materials, and joint development opportunities for organizations interested in science-driven partnerships.

Emerging Market Presence As a biotech startup with revenue between 1 million and 10 million, Kepley BioSystems presents an attractive target for bioscience investors, equipment suppliers, and industry partners seeking to expand into innovative health and environmental research markets.

Tech Stack & Digital Footprint With an established online presence utilizing popular web technologies and social media tools, the company is accessible for outreach, digital marketing collaborations, and technology solution providers aiming to enhance their engagement with biotech startups.